Simplifying Global Compliance
Final Combo Products cGMP Rule Contains Few Deviations From Draft
Devices & Diagnostics Letter
With few changes, the FDA has finalized a rule clarifying good manufacturing practice (GMP) requirements for single-entity and co-packaged drug-device products. The final rule, scheduled for publication in Tuesday’s Federal Register, takes effect on or about July 21.
To View This Article:
Subscribe To Devices & Diagnostics Letter
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing